Emeryville, California (EastBayDaily) — BioSoteria, Inc., Drug Safety and Risk Management Specialists, announced today that the article, “Effectiveness of REMS TOOLS” has been published in the August 2011 issue of the Global Forum. The article co-authored by BioSoteria’s CEO and President, Sally Van Doren, PharmD and Senior Vice President, James Buchanan, PharmD, reviews the Risk Evaluation and Mitigation (REMS) programs to date and the evidence for effectiveness of risk mitigation tools, as well as the methods used to evaluate them. The objective of the article is to discuss and present information on which REMS communication tools have influenced prescriber and patient behaviors leading to reduced product risks in patients.
To read more about the article, go to BioSoteria Publications and download BioSoteria’s article, “Effectiveness of REMS TOOLS” or view the article in the August 2011 issue of the DIA Global Forum.
About BioSoteria Founded in 2007 with a strong vision of a progressive drug safety and pharmacovigilance consulting services and education, BioSoteria serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information about BioSoteria and our safety consultative and training services, go to http://www.biosoteria.com.